GlassScriptPhysician profile
Ladonna Edwards
NPI 1609233964
$3,368.67
in general payments reported to CMS, 2019-2025
25 companies · $1,094 in 2025
The $1,094 reported for 2025 was more than what 86% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,005 · 2022: $606 · 2023: $377 · 2024: $286 · 2025: $1,094.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,371 · Travel and Lodging: $387.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,371.01 |
| Travel and Lodging | $386.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,031.23 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Collegium Pharmaceutical, INC. | $596.74 | 2021-2025 | Xtampza |
| Abbvie INC. | $293.13 | 2021-2025 | |
| Almatica Pharma LLC | $229.69 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $229.63 | 2021-2025 | Ztlido |
| Abbott Laboratories | $221.81 | 2021-2025 | Proclaim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $170.24 | 2022-2025 | Relistor |
| Biodelivery Sciences International, INC. | $94.73 | 2021 | |
| Amgen INC. | $92.52 | 2021-2022 | |
| Spr Therapeutics, INC | $52.18 | 2024-2025 | Sprint Pns System |
| Grt US Holding, INC. | $45.00 | 2022 | |
| Arbor Pharmaceuticals, INC. | $44.14 | 2021 | |
| Lilly USA, LLC | $42.18 | 2022 | |
| Mml US, INC. | $25.44 | 2025 | Reactiv8 |
| Averitas Pharma INC. | $21.74 | 2024 | Qutenza |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Virtus Pharmaceuticals LLC | $21.32 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $20.21 | 2025 | |
| Saluda Medical Americas, INC. | $20.03 | 2023 | Evoke Scs |
| Hikma Pharmaceuticals USA | $19.89 | 2022 | |
| Ibsa Pharma INC. | $19.15 | 2023 | Tirosint, Licart |
| Novartis Pharmaceuticals Corporation | $18.83 | 2021 | |
| Merit Medical Systems INC | $15.57 | 2024 | Stabilit System, Star Tumor Ablation System |
| Medtronic, INC. | $15.36 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $15.04 | 2022 | |
| Redhill Biopharma INC. | $12.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ladonna Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.